GAA AGC CGT ATG CTG ACA TTA CAG G-3'; g4, 5'-CAC CAA ACT CCA TTT GGA CTT ACA ATC C-3'; NE1, 5'-GGC TGA CCG CTT CCT CGT GCT TTA CGG TAT-3'; PU1, 5'-CAG CGC CCG ACC GAA AGG AGC GCA CGA CC-3' (Supplemental Figure 2B) .
Generation of adenoviral vectors
shRNA target sequences for chicken HSF2 mRNA were determined, and corresponding sense and antisense oligonucleotides (Supplemental Table 3 ) were annealed and inserted into pCR2.1-hU6 at an BamHI/HindIII site (pCR2.1-hU6-sh-cHSF2) (Fujimoto et al, 2010 ). An XhoI/HindIII fragment containing hU6-sh-cHSF2 was inserted into a pShuttle vector (Stratagene) at an XhoI/HindIII site (pShuttle-hU6-sh-cHSF2), and adenoviral DNA was generated according to the manufacturer's instructions for the AdEasy adenoviral vector system (Stratagene). Infectious adenovirus was generated by transfecting adenoviral DNA into HEK293 cells, and viral titers were determined as plaque forming units (pfu). To generate an adenoviral vector encoding cHSF2 or hHSF2, its cDNA was amplified by PCR using 5' primer containing a Kozak sequence and KpnI site, and 3' primer containing an XhoI site (Supplemental Table 4 ), and inserted into a pShuttle-CMV vector (Stratagene) at a KpnI/XhoI site. Adenoviral vectors encoding hHSF2 mutants, hHSF2R63G, hHSF2R63A, hHSF2ΔAB lacking amino acid 119 to 192, were constructed by a PCR-mediated method using the primers listed in Supplemental Table 4 as described previously (Inouye et al, 2003; Fujimoto et al, 2010) . Adenoviral DNA and infectious adenovirus were generated as described above.
Chemical crosslinking
Crosslinking of HSF3 was performed by incubating whole cell extracts with ethylene glycol bis(succinimidylsuccinate) (EGS) as described previously (Sarge et al, 1993) . Ad-sh-cHSF2-R3, or Ad-sh-cHSF2-R4 for 2 h, and maintained with normal medium for 46 h. 
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